Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
79.4
Signal Score
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (18)
○ MHRA GMP
Quick Facts: Curia (RNA/Advanced)
- Signal Score
- 79.4/100 (as of 2026-09-07)
- Quality Compliance
- 99.9/100
- Headquarters
- Albany, NY · Albuquerque, NM
- Modalities
- mRNA, Oligonucleotide, Biologics
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Curia (RNA/Advanced)
Formerly AMRI. Expanding into RNA therapeutics CDMO.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
99.9
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-12-02)
EMA GMP Certificates18 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, Oligonucleotide, Biologics
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
63.0
Profile-based capacity assessment
Curia (RNA/Advanced) FDA Inspection History
2025-12
2025-05
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-12-02 |
Curia Missouri, Inc.
Springfield, Missouri
Facility-linked
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2025-05-09 |
Curia Global, Inc.
Albany, New York
Facility-linked
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 06, 2026
Curia (RNA/Advanced) EMA GMP Compliance 18 certificates
2026-02
2026-02
2026-02
2026-02
2026-01
2025-11
2025-04
2025-03
2024-12
2024-06
2023-05
2023-02
2023-02
2023-02
2023-02
2023-02
2023-02
2023-02
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| 411/26 | Curia Spain S.A.U. | Spain | 2026-02-13 | COMPLIANT |
| 10350-004/26 | Curia Spain S.A.U. | Spain | 2026-02-13 | COMPLIANT |
| M00611-02/26 | Curia Spain S.A.U. | Spain | 2026-02-13 | COMPLIANT |
| M00611-03/26 | Curia Spain S.A.U. | Spain | 2026-02-13 | COMPLIANT |
| IT-API/41/H/2026 | Curia Italy S.r.l. | Italy | 2026-01-16 | COMPLIANT |
| 25MPP072HFR01 | Curia France S.A.S. | France | 2025-11-27 | COMPLIANT |
| IT-API/120/H/2025 | Curia Italy S.r.l. | Italy | 2025-04-11 | COMPLIANT |
| 25MPP015HFR01 | Curia France S.A.S. | France | 2025-03-28 | COMPLIANT |
| IT-API/29/H/2025 | Curia Italy S.r.l. | Italy | 2024-12-05 | COMPLIANT |
| 24MPP026HFR01 | Curia France S.A.S. | France | 2024-06-07 | COMPLIANT |
| IT-API/20/H/2024 | Curia Italy S.r.l. | Italy | 2023-05-25 | COMPLIANT |
| M00611-03/23/02 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| M00611-02/23/01 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| 10350-004/23 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| M00611-01/23 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| M00611-03/23 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| M00611-02/23 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| IT-API/265/H/2023 | Curia Italy S.r.l. | Italy | 2023-02-24 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Oct 06, 2026
Frequently Asked Questions About Curia (RNA/Advanced)
How many FDA inspections does Curia (RNA/Advanced) have on record?
CDMO Signal tracks 2 FDA inspections for Curia (RNA/Advanced), sourced from the FDA inspection database. See the full inspection history above.
Has Curia (RNA/Advanced) received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Curia (RNA/Advanced).
Does Curia (RNA/Advanced) hold EMA or MHRA GMP certificates?
CDMO Signal tracks 18 EMA GMP certificates for Curia (RNA/Advanced).
What is Curia (RNA/Advanced)'s CDMO Signal Score?
Curia (RNA/Advanced) has a Signal Score of 79/100, based on quality, operations, financial stability, and capacity data.
Evaluating Curia (RNA/Advanced) for a manufacturing program?
Use the free AI matchmaker to compare Curia (RNA/Advanced) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 81.1
mRNA, Oligonucleotide, Biologics
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 84.8
AAV, mRNA/LNP, Biologics, mRNA
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy